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ABSTRACT 
The spike glycoprotein of the SARS-CoV-2 virus, which causes COVID-19, has attracted attention for its 
vaccine potential and binding capacity to host cell surface receptors. Much of this research focus has centered 
on the ectodomain of the spike protein. The ectodomain is anchored to a transmembrane region, followed by 
a cytoplasmic tail. Here we report a distant sequence similarity between the cysteine-rich cytoplasmic tail of 
the coronavirus spike protein and the hepcidin protein that is found in humans and other vertebrates. Hepcidin 
is thought to be the key regulator of iron metabolism in humans. An implication of this preliminary observation 
is to suggest a potential route of investigation in the coronavirus research field making use of an already-
established literature on the interplay of local and systemic iron regulation, cytokine-mediated inflammatory 
processes, respiratory infections and the hepcidin protein. The question of possible homology and an 
evolutionary connection between the viral spike protein and hepcidin is not assessed in this report, but some 
scenarios for its study are discussed. 
 
 
MAIN TEXT 
1. Introduction 
As of mid-May 2020, 188 countries and regions are tackling the challenge of the pandemic caused by the 
novel coronavirus, with almost 5 million confirmed cases of infection worldwide (Center for Systems Science 
and Engineering, 2020). Coronaviruses, first described in the 1960s (Almeida et al., 1968; McIntosh, 2004), 
are mostly present in birds and mammals, and there has thus far been seven known coronavirus infectious 
disease outbreaks in humans causing respiratory illness (Hulswit et al., 2019; Seah et al., 2020). The four 
strains causing mild or common-cold-like symptoms are called 229E, NL63, OC43 and HKU1. The first two 
strains are in the ‘alpha’ coronavirus subgroup, whereas the latter two are ‘beta’ coronaviruses. The severe 
acute respiratory syndrome coronavirus (SARS-CoV-1) of 2002, the Middle East respiratory syndrome 
coronavirus (MERS-CoV) of 2012, and now the SARS-CoV-2 of 2019 (causing the ‘COVID-19’ disease) are 
the remaining three known coronaviruses (all of the beta subgroup) causing severe human disease (Andersen 
et al., 2020). This positive-sense single-stranded RNA virus family possesses the structural proteins spike (S), 
membrane (M) and envelope (E) proteins, along with the nucleocapsid (N) protein. It also has the largest 
genome among RNA viruses (Li, 2016). 
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 Much research interest is devoted to the spike (glyco)protein (forming the characteristic ‘corona’) and 
its importance in the development of vaccines and antivirals (Beniac et al., 2006; Du et al., 2009). The 
angiotensin-converting enzyme 2 (ACE2) is thought to be its (main, but perhaps not exclusive) receptor on 
human host cells (Wrapp et al., 2020; Xia et al., 2020). The spike protein is formed of a receptor-binding 
subunit (S1), a membrane-fusion subunit (S2), a single-pass transmembrane (TM) domain, and a 
cytoplasmic/intracellular tail (CT) (Li, 2016; Shang et al., 2020). Of note, the S1 domain has a similar fold as 
human galectins (galactose-binding lectins) (Peng et al., 2011). Briefly, in terms of the putative primary function 
of the spike protein, Li comments that “because coronaviruses must enter cells for replication, membrane 
fusion is the central function of coronavirus spikes” (Li, 2016). 
 
2. Search for Sequence Similarity 
A basic question that might arise is: what exactly makes the pathobiology and disease course of these 
particular viruses unique? And, could it be that, in addition to viral replication inside the particular types of 
human host cells, other intracellular processes specific to these viruses are involved? Having this in mind, we 
wondered if there might be any sequence similarity (and thereby potentially structural similarity) between the 
SARS-CoV-2 spike protein (which has 1,273 amino acids (Wu et al., 2020a)) and any vertebrate protein(s). 
A simple BLAST search does not reveal any similarities with human proteins. However, based on 
previous experience with the pufferfish Takifugu rubripes proteome (Ehsani, 2015; Ehsani et al., 2011; Schmitt-
Ulms et al., 2009) and its unique evolutionary history, we initially restricted the search to this species. Teleost 
ancestor species underwent an ancient whole-genome duplication event (Van de Peer, 2004), and teleost 
species with well-annotated genomes such as the pufferfish can provide invaluable insights into the sequence 
evolution of genes with a clear phylogenetic linkage to mammalian genes (for a related commentary, see 
(Lidgard and Love, 2018)). Interestingly, a query using the full-length SARS-CoV-2 spike protein (accession 
no. YP_009724390.1) revealed a sole hit with the pufferfish hepcidin (Go et al., 2019) protein 
(XP_003965681.1; score: 32.7, E-value: 0.54). Given that SARS-like coronaviruses can be found in bats (Wu 
et al., 2020b), we also used a full-length bat coronavirus sequence (ANA96027.1) as the query, which showed 
a closer match with pufferfish hepcidin (score: 38.5, E-value: 0.005). Conversely, a BLAST search in the 
Coronaviridae family of viruses using the pufferfish hepcidin (XP_003965681.1) revealed the bat coronavirus 
spike protein (ANA96027.1) as the top hit (score: 38.5, E-value: 5e-04). The scores and E-values here are not 
meant to indicate any claims of statistical significance but rather are provided for the purpose of comparison. 
This similarity between the spike protein and hepcidin is at the cytoplasmic tail (McBride et al., 2007) 
of the spike protein, or, depending on the exact domain delineation, perhaps at the junction between the TM 
and CT domains. A multiple sequence alignment of this sequence region (generated using the AlignX feature 
of Vector NTI Advance 11.0, Invitrogen, Carlsbad, CA, USA), using three coronavirus spike proteins and four 
hepcidin proteins (from pufferfish, bat and human) is illustrated in Figure 1A. 
The alignment depicts a number of conserved motifs, particularly between the first pufferfish hepcidin 
sequence (various pufferfish species have at least two hepcidin-like genes (Go et al., 2019)) and the 
coronavirus spike proteins. In a sense, the pufferfish sequence seems to act as a ‘bridge’ between the 
coronavirus motifs and those in the human hepcidin sequence. This may not be surprising particularly given 
the evolutionary context of teleost species described earlier. The similar cysteine-rich motif takes the following 
form: ‘LXXXTXCCXCCKGXXXCGXCC(R/K)F’. Of note, the eight cysteines of the mature human hepcidin in 
the similarity motif, and the aligned cysteines of the SARS-CoV-2 spike protein, are not all specifically coded 
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by one of the two cysteine-coding codons (TGC and TGT). Both codons are present in the respective gene 
segments. Also, for comparison purposes, as the coronavirus envelope protein (Schoeman and Fielding, 2019) 
contains a related ‘LCAYCCN’ motif (Wu et al., 2003), this sequence was also added as the last line of the 
alignment. 
 This is a distant and limited sequence similarity, and no claims about homology and sequence 
conservation can be made at present. Nevertheless, this raises a potential and intriguing question of whether 
there could be mimicry of human hepcidin (structural, functional or otherwise), perhaps inside the host cell, by 
the TM-CT junction of the spike protein. It should be noted that it is unlikely for the sequence similarity reported 
here to be due to the relatively cysteine-rich composition of hepcidins. When searching all available teleost 
proteomes using the aforementioned bat coronavirus sequence, hepcidins are the only hits, even though they 
are clearly not the only cysteine-rich proteins. Moreover, in addition to various hepcidin orthologs containing 
eight cysteines, four-cysteine variants have been described in notothenioid fish species (Xu et al., 2008). 
 
3. The Hepcidin Protein 
Hepcidin is a small peptide hormone that was discovered in 2000/2001 (Andrews, 2008; Hunter et al., 2002; 
Krause et al., 2000; Park et al., 2001; Pigeon et al., 2001), and initially named LEAP-1 (liver-expressed 
antimicrobial peptide). It has an antiparallel beta-sheet fold and contains four disulfide bonds, and is involved 
in iron trafficking and the host’s response to infection (Drakesmith and Prentice, 2012). In fact, it has been 
remarked by a number of commentators that “hepcidin is to iron, what insulin is to glucose” (Grover, 2019). 
Clear hepcidin orthologs appear to be missing in birds and invertebrates (Prentice, 2017). The human hepcidin 
(encoded by the HAMP gene on chromosome 19q13) is an 84-amino-acid prepropeptide, leading to a mature 
25-amino-acid peptide that is detectable in blood and urine (Jordan et al., 2009). The proprotein convertase 
furin has been demonstrated to cleave prohepcidin at a polybasic site (Lee, 2008; Valore and Ganz, 2008). Of 
note, a furin-like cleavage site (‘RRAR’) has recently been reported to exist in the ectodomain of the SARS-
CoV-2 spike protein, which is absent in coronaviruses of the same clade (Coutard et al., 2020). The protein-
coding part of the HAMP gene is split over three exons, with the 25-amino-acid mature peptide occurring on 
the last exon. In terms of its putative function(s), Prentice notes that “although the hepcidin molecule does 
itself possess some antimicrobial activity, this is rather weak compared to peptides such as defensins, and its 
primary contribution to innate immunity is via regulation of iron” (Prentice, 2017). Hepcidin binds to and 
mediates the degradation of ferroportin (encoded by the SLC40A1 / FPN1 gene), the only known cellular iron 
exporter. The structural details of this interaction are being mapped and studied in ever more detail (Billesbølle 
et al., 2020; Muriuki et al., 2019; Ren et al., 2020). 
 
4. Hepcidin and the CoV Spike Protein 
4.1. Available Structures and Structural Predictions 
There are a number of solved structures of hepcidin (Jordan et al., 2009; Lauth et al., 2005). An NMR structure 
of human hepcidin is depicted in Figure 1B (visualized using 3-D Molecule Viewer, Vector NTI Advance 11.0, 
Invitrogen) including the locations of the four putative disulfide bonds. Available solved structures of the 
coronavirus spike glycoprotein, as far as our search could reveal, mostly utilize expression constructs that stop 
just short of the TM domain. As noted, this is partly because the protein’s ectodomain is the main focus of 
studies on viral binding to host surface receptors (Walls et al., 2020; Wrapp and McLellan, 2019; Wrapp et al., 
2020). For example, Wrapp, Wang and colleagues have reported the cryo-electron microscopy structure of 
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ectodomain residues 1-1,208 of the spike protein (trimer in the prefusion conformation) (Wrapp et al., 2020), 
but this excludes the TM and CT domains. It goes without saying that the inclusion of transmembrane domains 
would require complicated structural elucidation protocols, and even then, one may still not be able to solve 
the structure of the protein in its entirety. 
Moreover, we would like to note that using the Pfam-A (ver. 32) structural/domain database (Finn et 
al., 2008) in the HHpred remote homology and structure prediction toolkit (Zimmermann et al., 2018), the 
coronavirus spike protein regions analyzed here show some predicted structural similarity to lipolysis-
stimulated receptor (LSR) lipoprotein receptor family (PF05624) (Yen et al., 1999), and hepcidin sequences 
show some predicted structural similarity to the Sar8.2 protein family found in Solanaceae plants (PF03058) 
(Alexander et al., 1992). What, if any, significance these findings may hold is unclear at present. Of more 
importance right now would be the theoretical and/or actual elucidation of the structure of the spike protein 
TM-CT junction region and a comparison with the available hepcidin structures (the Pfam hepcidin entry, 
PF06446, currently references six PDB structures). 
 
4.2. Posttranslational Modifications 
Given the prominence of cysteines in the aligned motif (Figure 1A), how are they utilized in the respective 
similar domains? At first pass, the usages appear to be different: as noted earlier, in hepcidin, the cysteines 
may give rise to a compact disulfide-bridged peptide (Jordan et al., 2009; Nemeth and Ganz, 2009) (Figure 
1B), whereas in coronavirus spike glycoproteins, the cysteines in the TM-CT junction serve as palmitoylation 
acceptor residues (Shulla and Gallagher, 2009) (Figure 1C) that facilitate membrane fusion (Chang et al., 
2000). It should be mentioned, however, that ‘mini-hepcidins’ conjugated to palmitoyl groups have been 
synthesized and studied previously (Preza et al., 2011), but these do not occur naturally. As for the SARS-
CoV, at least a portion of the palmitoylation of the spike protein has been reported to occur in a pre-medial 
Golgi compartment (McBride and Machamer, 2010). However, there is also the possibility of cross-disulfide 
bond formation with a non-homologous small cluster of cysteines within the envelope protein (Wu et al., 2003). 
Moreover, if S-palmitoylation is a reversible and dynamic process (Sobocinska et al., 2017), it is to be 
determined if the spike protein junction cysteines might in fact have a different posttranslational modification 
in the host cytoplasmic environment (although there is no evidence of this at the moment, and the reversibility 
of palmitoylation in viral spike proteins has not been reported (Gadalla and Veit, 2020)). That being said, in the 
cited paper by McBride and Machamer, the authors conclude that the palmitoylation of the SARS-CoV spike 
protein “was not necessary for S protein stability, trafficking or subcellular localization” nor “for efficient 
interaction with M protein” (McBride and Machamer, 2010). To what extent the posttranslational modifications 
of the spike protein and hepcidin, be it furin cleavage, disulfide bonds or palmitoylation, are in any way similar 
in an intracellular context, remains to be examined. 
 
4.3. Scenarios for the Investigation of Homology and Evolutionary Connections 
In terms of the possibility of an evolutionary connection between the spike protein and hepcidin, one could 
imagine a scenario whereby an ancestral spike protein acquired a hepcidin-like sequence from a host 
organism, and the new sequence was palmitoylated to aid with membrane association. Li points out that “the 
primordial form of coronavirus spikes might contain S2 only” (Li, 2016), and the cytoplasmic motif features 
highlighted in the current report do not appear to be present in other class I viral membrane fusion proteins 
(which include the influenza virus (Bosch et al., 2003; Kielian, 2014)), although we have not performed an 
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exhaustive search. However, a number of questions might then arise under this scenario, such as the 
difference between the primary localizations of hepcidin (considering its putative interaction with extracellular 
and transmembrane regions of ferroportin (Billesbølle et al., 2020; Ren et al., 2020)) versus the CT domain of 
the spike protein. Alternatively, it might be argued that perhaps a case of convergent sequence evolution is at 
play. For example, the influenza virus hemagglutinin glycoprotein appears to have a conserved ‘CXICI’ motif 
in its cytoplasmic tail domain (Nobusawa et al., 1991; Wagner et al., 2005), and perhaps an ancestral spike 
protein with similar features convergently acquired hepcidin-like sequence motifs. These are of course 
speculations and remain open questions. Investigations pursuing these topics could also make use of studies 
that attempt to trace the evolutionary history of hepcidin itself (Kim et al., 2019; Xu et al., 2008). 
 
5. Potential Leads for Coronavirus Research 
One of the first questions that may arise from this potential sequence similarity is whether the comparison is 
equal for all seven known human coronavirus strains, or if it is more limited to the severe disease-causing 
viruses. Figure 2 depicts a sequence alignment to start to answer this question. The alignment is restricted to 
the length of the mature human hepcidin protein, which is depicted at the bottom row. The first four spike 
protein sequences are comprised of the mild/asymptomatic strains, i.e., 229E and NL63 (alpha coronaviruses) 
and HKU1 and OC43 (beta coronaviruses). These are followed by the spike proteins of MERS-CoV, SARS-
CoV-1 and SARS-CoV-2. The bat coronavirus sequence and the four hepcidins are depicted in the same order 
as in Figure 1A. Paying particular attention to the region between the two conserved cysteines (marked by 
two black arrows), there appears to be less similarity in the motif between the first four spike proteins than the 
rest of the sequences. Specifically, for example, a ‘conserved’ glycine in the sixth position from the first overall-
conserved cysteine (indicated with a red arrow) appears to be an important residue that groups together the 
three disease-causing spike proteins with the bat sequence and the two teleost hepcidin proteins. How, if at 
all, these differences play out in the cell might be an intriguing experimental direction. 
 What can also be noted from Figure 2 is that although there are appreciable differences in the spike 
protein domains visualized in the figure between the MERS-CoV and the two SARS-CoV sequences, the 
SARS-CoV-1 and SARS-CoV-2 spike proteins are almost identical in this region. Therefore, based on the 
hypothetical link presented in this report, any pathobiological differences between the two SARS strains would 
not be as a result of any differing biology attributable to the hepcidin similarity domain. For reference, the 
SARS-CoV-2 genome has been reported to be 96% identical to bat CoV (nucleotide identity), 80% to SARS-
CoV-1, 55% to MERS-CoV and 50% to common cold CoV (e.g., the 229E and OC43 strains) (Bar-On et al., 
2020).  
 More broadly, the potential sequence link reported here points to the need to build on previous 
research on the cytoplasmic tail of the spike protein (e.g., (McBride et al., 2007; Petit et al., 2007; Petit et al., 
2005)) to better understand its distinct roles from the time of viral attachment to possible protein-protein 
interactions inside the host cell. Of the rare mutations currently reported in the SARS-CoV-2 spike protein, only 
one (P1263L) appears to be in the cytoplasmic tail domain (Korber et al., 2020), placing it outside of the 
similarity region reported here. 
 The sequence similarity also points to a focus on iron biology. Following calcium, oxygen and lead, 
iron has historically been one of the most studied elements in cell biology (Ehsani, 2013), and as such there 
is a vast body of (at times conflicting) literature to draw upon relating to coronavirus infections. Other 
investigators have reviewed broad themes from iron biology in the context of COVID-19 (Liu et al., 2020), and 
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so here I will only stay on the topic of hepcidin. Foremost among the potential physiological connections related 
to this discussion is the so-called ‘cytokine storm’ mediated by interleukin-6 (IL-6) reported in some COVID-19 
patients (Mehta et al., 2020; Moore and June, 2020; Xu et al., 2020). Hepcidin production in the liver is induced 
by IL-6, and this is especially well-studied in the anemia of inflammation literature (Ganz, 2019; Noguchi-
Sasaki et al., 2016). Related to the role of IL-6, it has been reported that hepatic heparan sulfate affects and 
regulates IL6-stimulated hepcidin expression (Poli et al., 2019). Furthermore, heparin, the anticoagulant 
glycosaminoglycan that is a highly sulfated form of heparan sulfate, has been shown to be a potent inhibitor 
of hepcidin expression (Poli et al., 2011). Of interest, anticoagulant treatment has been reported to be effective 
in a subset of severe COVID-19 patients (Tang et al., 2020). 
 Less established, but still important to mention, is the current debate surrounding the issue of 
hypoxia/hypoxemia and certain symptoms resembling, but differentiable from, altitude illness (Archer et al., 
2020; Arias-Reyes et al., 2020; Basnyat et al., 2020; Gattinoni et al., 2020). Congruously, hepcidin expression 
levels have also been investigated in the context of high-altitude acclimatization (Hennigar et al., 2020) (see 
also (Choque-Quispe et al., 2020)). A second, not yet fully-established, link of relevance here is the recent 
observations of a Kawasaki-disease-like systemic vasculitis syndrome in children infected with the novel 
coronavirus (Jones et al., 2020; Verdoni et al., 2020), which is also being called pediatric multisystem 
inflammatory syndrome. Incidentally, an association between a novel human coronavirus and Kawasaki 
disease was reported in 2005 (Esper et al., 2005), although other investigators were apparently not successful 
in confirming the link (Ebihara et al., 2005). Nevertheless, if the association with the Kawasaki-disease-like 
syndrome is real, then it is noteworthy that increased hepcidin levels have been suggested as a biomarker for 
Kawasaki disease (Huang et al., 2018). 
 Given the central role of hepcidin in iron metabolism, it is also important to point to a number of 
circumstantial but perhaps important findings in the literature pertaining to lung disease. These include (i) a 
link between SARS and liver function abnormalities (Lefkowitch, 2005), (ii) the association of pulmonary iron 
overload and restrictive lung disease (Ganz, 2017; Neves et al., 2017a), (iii) the role of iron in pulmonary 
fibrosis (Ali et al., 2020), and (iv) hepcidin’s modulation of the proliferation of pulmonary artery smooth muscle 
cells (Ramakrishnan et al., 2018). Furthermore, (v) hepcidin upregulation along with serum iron reduction has 
been reported in influenza infections (Armitage et al., 2011; Fernandez, 1980). Importantly, however, iron 
dysregulation changes may only be at a local cellular/tissue level and not reach a systemic response (Lakhal-
Littleton et al., 2019), and may demonstrate selective tissue tropisms during different viral infections (Armitage 
et al., 2014). 
 Moving back to the biology of the hepcidin protein itself, as noted previously, hepcidin binds to and 
mediates the degradation of the iron exporter ferroportin. If the sequence similarity reported here is actually 
playing a significant role at the cellular level, could it be that, although the cellular localizations appear to be 
different based on current knowledge, the SARS-CoV-2 spike protein cytoplasmic tail can partly mimic the 
structure of hepcidin and interact with ferroportin? Could the cytoplasmic tail even coordinate and bind iron? 
These remain to be investigated experimentally, but of note, Rishi and colleagues recently reported on the 
intracellular localization of ferroportin dimers, and concluded that both the carboxy- and amino-termini of the 
protein are intracellular (Rishi et al., 2020). As cited earlier, the details of hepcidin’s own interaction sites with 
ferroportin remain the subject of different structural determination projects (Billesbølle et al., 2020; Ren et al., 
2020). Relatedly, and of interest, Neves and colleagues, using experiments on iron overload in European bass 
(Dicentrarchus labrax), discuss the functional partnership between hepcidin and ferroportin from an 
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evolutionary perspective, and suggest that this may “open new possibilities for the pharmaceutical use of 
selected fish […] hepcidins during infections, with no impact on iron homeostasis” (Neves et al., 2017b). 
 Finally, and specific to COVID-19, a number of broader questions that could follow up from this work 
are: first, does the spike protein, similar to hepcidin, potentially promote iron sequestration in (alveolar) 
macrophages (Michels et al., 2015) and hence impede the host’s immunological response? Second, could a 
recent report of the common presence of digestive symptoms in COVID-19 patients (Pan et al., 2020) be 
explainable in part by a link to hepcidin? And third, could systemic changes in serum iron levels (Shah et al., 
2020; van Swelm et al., 2020; Zhang and Liu, 2020) (with a possible view on the degree of above-normal 
serum ferritin in patients (Chen et al., 2020)) or levels of hepcidin itself be detected in patients with varying 
COVID-19 severities? With respect to the biology surrounding reports of gastrointestinal symptoms, it is 
important to point out that a recent study concluded that in gut epithelial cells, the “expression of two mucosa-
specific serine proteases, TMPRSS2 and TMPRSS4, facilitated SARS-CoV-2 spike fusogenic activity and 
promoted virus entry into host cells” (Zang et al., 2020). It is also known that the liver-specific serine protease 
TMPRSS6 (matriptase-2) negatively modulates hepcidin (Beliveau et al., 2019; Du et al., 2008). Overall, the 
observations in this report suggest that, as a starting point, (serum) iron status would be a critical data category 
to be systematically collected from patients at various stages of the disease’s progression. Serum ferritin levels 
are usually considered a general indicator of inflammation and infection, and as pointed out by Baron and 
colleagues, “the use of ferritin to diagnose iron deficiency may be problematic in patients with COVID‐19 
disease, who may have normal or high ferritin levels despite very low iron stores” (Baron et al., 2020). Be that 
as it may, iron homeostasis in the case of COVID-19 may be a more specific pathobiological feature of this 
infection, and we can only know the answer to this scenario if more data related to iron biology is gathered 
during the current pandemic.  
 
6. Conclusion 
Theoretical analyses in new areas may necessarily entail reasonable speculations based on limited or 
disparate data. This is expected, but one should remain cognizant of overinterpretation, and pursue a rational 
course of theoretical inquiry to hopefully inform subsequent experimental investigations. Here, a purposeful 
and restricted protein sequence search revealed a potential sequence similarity between the relatively less-
studied cysteine-rich cytoplasmic domain of coronavirus spike proteins and the vertebrate hepcidin protein. 
This is quite unlikely to be a spurious and random similarity. There are many cysteine-rich protein sequences 
in vertebrates, but the motif identified here is unique and specific, and also appears to tentatively set apart the 
disease-causing strains from the milder coronavirus strains. Following from this link, a number of emerging 
clinical strands of evidence (summarized in Table 1) were discussed which further link a biology surrounding 
hepcidin with coronavirus-caused pathobiology. While each piece of clinical evidence discussed does not by 
itself provide overwhelming corroboration for the hypothesis of the paper, the totality of evidence presented 
we believe make a strong case that if sequence and/or structural mimicry to hepcidin is taking place upon viral 
attachment to and entry in the host cell, then perhaps a local disease condition resembling iron dysregulation 
(e.g., iron overload) might result in the infected tissue(s). This hypothesis can be immediately tested in one of 
three ways. First, in the clinic, levels of various serum markers for iron biology could be more systematically 
and comprehensively measured and analyzed. Second, computational investigations could examine potential 
structural mimicry between the two proteins and explore the effect of differing posttranslational modifications. 
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And third, the potential link to hepcidin could be relied upon in cell-based assays to determine the possibility 
of the involvement of the spike protein in iron biology. 
 
 
TABLE 
Table 1. Points of similarity and divergence between hepcidin and the coronavirus spike protein cytoplasmic 
domain based on current knowledge of the viral protein and its pathobiology (see main text for references) 
Potential Similarities Potential Differences 
1. Protein sequence: A unique but restricted 
sequence similarity exists between mature 
hepcidin and the cysteine-rich cytoplasmic 
tail of coronavirus spike proteins. 
1. Protein length and domains: Coronavirus 
spike proteins are much larger, multi-
domain, proteins compared to the relatively 
short-length hepcidin proteins. 
2. Posttranslational processing: The 
proprotein convertase furin cleaves 
prohepcidin, and has been reported to also 
activate (the ectodomain of) the SARS-
CoV-2 spike protein. 
2. Posttranslational modification: 
Cysteines in the cytoplasmic tail of 
coronavirus spike proteins are thought to 
be palmitoylation acceptor residues, and 
this modification has thus far not been 
reported to be reversible. Cysteines in 
hepcidin are used to form disulfide bonds. 
3. Cytokine storm: IL-6-mediated 
inflammatory responses have been 
reported in COVID-19 patients. Hepcidin 
production in the liver is induced by IL-6 
and is well-studied in the context of anemia 
of inflammation. In addition, COVID-19 may 
be associated with a Kawasaki-disease-like 
systemic vasculitis manifestation in 
children, and hepcidin levels have also 
been suggested as a biomarker for 
Kawasaki disease. 
3. Localization: Hepcidin is thought to 
interact with its main (iron-bound) interactor 
ferroportin extracellularly, whereas the 
spike protein cytoplasmic tail does not face 
the environment outside the viral 
membrane. (However, the cytoplasmic tail 
associates with the plasma membrane 
itself aided by its palmitoylation 
modifications, and hepcidin may interact 
with ferroportin close to ferroportin’s 
transmembrane regions in addition to 
extracellular residues.) 4. Hypoxia/Hypoxemia: COVID-19 may lead 
to symptoms resembling, but differentiable 
from, altitude illness, and hepcidin 
expression levels have also been studied in 
the context of high-altitude acclimatization. 
 
 
FIGURE LEGENDS 
Figure 1. Comparison of select hepcidin and coronavirus spike protein sequences. (A) A multiple 
sequence alignment of the C-terminal region of a number of coronavirus spike proteins (encompassing 
portions of the putative transmembrane and cytoplasmic tail segments), four hepcidins and the SARS-CoV-2 
envelope protein is presented. The envelope sequence is provided only to demonstrate the cysteine residues 
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with which the spike protein is proposed to form disulfide bridges (Wu et al., 2003). The residue numbers are 
shown on the sides of each protein segment, and for proteins whose C-terminal sequences continue beyond 
the alignment, the full residue length is provided to the right. As per a color scheme used previously (Schmitt-
Ulms et al., 2009), dark green, grey and black highlights depict conserved, similar and identical residues, 
respectively. ‘Tr’ stands for Takifugu rubripes (Japanese pufferfish), ‘Rf’ for Rhinolophus ferrumequinum 
(greater horseshoe bat) and ‘Hs’ for Homo sapiens (human). The protein accession numbers of the sequences 
shown are, in order: (1) AWH65954.1, (2) YP_009724390.1, (3) ANA96027.1, (4) XP_003965681.1, (5) 
XP_029694670.1, (6) ENSRFET00010014064.1, (7) NP_066998.1 and (8) QHD43418.1. The domain 
illustration of the spike protein is based on (Wrapp et al., 2020). (B) A solved NMR structure of human hepcidin 
(Jordan et al., 2009) (PDB: 2KEF), adopting an antiparallel beta-sheet fold, is visualized with its putative four 
disulfide bonds formed between eight cysteine residues. (C) The position of the disulfide bonds in the 
sequence of the mature human hepcidin is illustrated along with the potential palmitoylation residues (ten 
cysteines) of the cytoplasmic tail of the SARS-CoV-2 spike protein. The palmitate visual is as per (Linder and 
Deschenes, 2007). 
 
Figure 2. Comparison of core hepcidin-like motif among the seven known coronavirus human 
infection-causing strains. Following the alignment presented in Figure 1A, the core similarity motif, 
corresponding to the length of the mature human hepcidin sequence, is shown in an alignment containing the 
spike protein cytoplasmic domain of the four mild/asymptomatic human coronavirus strains and the three 
severe-disease-associated strains. Hepcidin sequences from the previous figure appear on the last four lines. 
The alignment color scheme is the same as in Figure 1. Focusing on the region between the two black arrows, 
fewer similar residues could be observed between the group of mild/asymptomatic coronavirus strains and the 
MERS/SARS-CoV strains. One such residue that can act to distinguish the groups is indicated with a red 
arrow. The accession numbers of the sequences shown, in order of appearance, are: (1) ARU07601.1, (2) 
AFD98827.1, (3) AZS52618.1, (4) AXX83351.1, (5) AWH65954.1, (6) NP_828851.1, (7) YP_009724390.1, (8) 
ANA96027.1, (9) XP_003965681.1, (10) XP_029694670.1, (11) ENSRFET00010014064.1 and (12) 
NP_066998.1. 
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FIGURE 1
MERS-CoV_Spike  1287   QKWPWYIWLGFIAGLVALALCVFFLLCCTGCGTNCMGKLKCNRCCDK   1333 ... 1347 
SARS-CoV-2_Spike  1210   IKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKF   1256 ... 1273 
Bat-CoV_Spike  1173   IKWPWYVWLGFIAGLVGLFMAIILLCYFTSCCSCCKGMCSCGSCCRF   1219 ... 1236 
Tr_Hepcidin-1    44   VAHQEMSMDSWMMPNHSRQKRQSHLSLCTLCCNCCKGNKGCGFCCRF   90 
Tr_Hepcidin-2    42   GAAVYEEMPVDSWKMPYTNRHKRSPKRCKFCCNCCPGMRGCGVCCRF   88 
Rf_Hepcidin    82   TQDTAGAKAGWTPGLRRLRRRDAHFPICIYCCGCCY-KSRCGLCCKT   127 
Hs_Hepcidin    39   PQDRAGARASWMPMFQRRRRRDTHFPICIFCCGCCH-RSKCGMCCKT   84 
SARS-CoV-2_Envelope    1   MYSFVSEETGTLIVNSVLLFLAFVVFLLVTLAILTA-LRLCAYCCNI   46   ... 75 
 
                                                 |--------------------------| 
                                                  DTHFPICIFCCGCCH-RSKCGMCCKT 
                                                    mature human hepcidin peptide 
S1 S2
receptor-binding subunit membrane-fusion subunit
signal
sequence
transmembrane
domain
cytoplasmic
tail
1 1273SARS-CoV-2
Spike Protein
C
Human Hepcidin
(PDB: 2KEF)
N
C1
2
3 4
56
7
8
S-S
S-S
S-
S
S-
S
 
SARS-CoV-2_Spike  1231   TIMLCCMTSCCSCLKGCCSCGSCCKF   1256 ... 1273 
 
Hs_Hepcidin    60   DTHFPICIFCCGCCH-RSKCGMCCKT   84 
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FIGURE 2
HCoV-229E_Spike  1131   LLLCCCSTGCCGFFSCFASSIKGCCE   1156 ... 1171 
HCoV-NL63_Spike  1314   LVFCCLSTGCCGCCNCLTSSMRGCCD   1339 ... 1356 
HCoV-HKU1_Spike  1313   LFFICCCTGCGSACF--SKCHNCCDE   1336 ... 1351 
HCoV-OC43_Spike  1324   LFFICCCTGCGPSCF--KKCGGCCDD   1347 ... 1362 
MERS-CoV_Spike  1308   VFFLLCCTGCGTNCMGKLKCNRCCDK   1333 ... 1347 
SARS-CoV-1_Spike  1213   TILLCCMTSCCSCLKGACSCGSCCKF   1238 ... 1255 
SARS-CoV-2_Spike  1231   TIMLCCMTSCCSCLKGCCSCGSCCKF   1256 ... 1273 
Bat_CoV_Spike  1194   IILLCYFTSCCSCCKGMCSCGSCCRF   1219 ... 1236 
Tr_Hepcidin-1    65   QSHLSLCTLCCNCCKGNKGCGFCCRF   90 
Tr_Hepcidin-2    63   KRSPKRCKFCCNCCPGMRGCGVCCRF   88 
Rf_Hepcidin   103   DAHFPICIYCCGCCY-KSRCGLCCKT   127 
Hs_Hepcidin    60   DTHFPICIFCCGCCH-RSKCGMCCKT   84 
 
